Literature DB >> 22371336

Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays.

Maria Dolores Tabernero1, Angel Maíllo, Ana Belen Nieto, Cristina Diez-Tascón, Mónica Lara, Pablo Sousa, Alvaro Otero, Abel Castrillo, Maria del Carmen Patino-Alonso, Ana Espinosa, Carlos Mackintosh, Enrique de Alava, Alberto Orfao.   

Abstract

Despite recent advances in the identification of the cytogenetic profiles of meningiomas, a significant group of tumors still show normal karyotypes or few chromosomal changes. The authors analyzed the cytogenetic profile of 50 meningiomas using fluorescence in situ hybridization and high-density (500 K) single nucleotide polymorphism (SNP) arrays. Our results confirm that del(22q) (52%) and del(1p) (16%) (common deleted regions: 22q11.21-22q13.3. and 1p31.2-p36.33) are the most frequent alterations. Additionally, recurrent monosomy 14 (8%), del(6q) (10%), del(7p) (10%), and del(19q) (4%) were observed, while copy number patterns consistent with recurrent chromosomal gains, gene amplification, and copy number neutral loss of heterozygosity (cnLOH) were either absent or rare. Based on their overall SNP profiles, meningiomas could be classified into: (i) diploid cases, (ii) meningiomas with a single chromosomal change [e.g., monosomy 22/del(22q)] and (iii) tumors with ≥2 altered chromosomes. In summary, our results confirm and extend on previous observations showing that the most recurrent chromosomal abnormalities in meningiomas correspond to chromosome losses localized in chromosomes 1, 22 and less frequently in chromosomes 6, 7, 14, and 19, while chromosomal gains and cnLOH are restricted to a small proportion of cases. Finally, a set of cancer-associated candidate genes associated with the TP53, MYC, CASP3, HDAC1, and TERT signaling pathways was identified, in cases with coexisting monosomy 14 and del(1p).
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22371336     DOI: 10.1002/gcc.21948

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma.

Authors:  Cheng-Ying Ho; Stacy Mosier; Janice Safneck; Diva R Salomao; Neil R Miller; Charles G Eberhart; Christopher D Gocke; Denise A S Batista; Fausto J Rodriguez
Journal:  Brain Pathol       Date:  2014-05-21       Impact factor: 6.508

2.  Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype.

Authors:  Patrícia Henriques Domingues; Pablo Sousa; Álvaro Otero; Jesus Maria Gonçalves; Laura Ruiz; Catarina de Oliveira; Maria Celeste Lopes; Alberto Orfao; Maria Dolores Tabernero
Journal:  Neuro Oncol       Date:  2014-02-16       Impact factor: 12.300

3.  MMAPPR: mutation mapping analysis pipeline for pooled RNA-seq.

Authors:  Jonathon T Hill; Bradley L Demarest; Brent W Bisgrove; Bushra Gorsi; Yi-Chu Su; H Joseph Yost
Journal:  Genome Res       Date:  2013-01-08       Impact factor: 9.043

Review 4.  Genetic/molecular alterations of meningiomas and the signaling pathways targeted.

Authors:  Patrícia Domingues; María González-Tablas; Álvaro Otero; Daniel Pascual; Laura Ruiz; David Miranda; Pablo Sousa; Jesús María Gonçalves; María Celeste Lopes; Alberto Orfao; María Dolores Tabernero
Journal:  Oncotarget       Date:  2015-05-10

5.  Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.

Authors:  MariaDolores Tabernero; María Jara-Acevedo; Ana B Nieto; Arancha Rodríguez Caballero; Alvaro Otero; Pablo Sousa; Jesús Gonçalves; Patricia H Domingues; Alberto Orfao
Journal:  BMC Med Genet       Date:  2013-10-30       Impact factor: 2.103

6.  Identification of shared genomic aberrations between angiomatous and microcystic meningiomas.

Authors:  Yasuhiro Kuroi; Hiroyuki Akagawa; Makoto Shibuya; Hideaki Onda; Tatsuya Maegawa; Hidetoshi Kasuya
Journal:  Neurooncol Adv       Date:  2019-09-28

7.  An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.

Authors:  José Carlos Iglesias Gómez; Adrián Mosquera Orgueira
Journal:  Front Oncol       Date:  2014-06-23       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.